CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Previous 10% Owner sold 2,383,090 shares at $2.16 ($5,137,942)
- 4 Shares withheld for taxes President and CEO gave up 5,343 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,343 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 21,371 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 4,000,000 shares at $1.66 ($6,640,000)
- 4 Open-market buy Director bought 24,553 shares at an average $0.98 ($24,045)
- 4 Open-market buy General Counsel/Secretary bought 5,000 shares at $1.02 ($5,100)
- 4 Open-market buy CFO & SVP, Finance bought 5,000 shares at $1.01 ($5,050)
- 4 Open-market buy President and CEO bought 10,000 shares at $1.01 ($10,100)
- 4 Open-market sale 10% owner sold 2,250,000 shares at $2.00 ($4,500,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 36 · 720 filings